# Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea (HPV-STAT)

Source: https://onco.cc/key-papers/paper-vallely-hpv-stat-png-lancetgh-2022/  
OnCo record `paper-vallely-hpv-stat-png-lancetgh-2022` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

In 4,285 women in Papua New Guinea who took their own vaginal sample for a point-of-care HPV test, 93% of those who tested positive were treated with thermal ablation the same day, and the strategy detected 85% of high-grade lesions.

## Summary

HPV-STAT was a large single-arm intervention trial at two clinical sites in Papua New Guinea, from June 2018 to January 2020. Women aged 30 to 59 self-collected a vaginal specimen for point-of-care GeneXpert HPV testing; those who tested positive had a pelvic examination and same-day thermal ablation or referral. The authors call it the first real-world evaluation of a fully integrated self-collect, test and treat strategy for same-day cervical screening in a low- or middle-income country. Registered as ISRCTN13476702 and funded by Australia's National Health and Medical Research Council.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: The Lancet Global Health
- Year: 2022
- DOI: 10.1016/S2214-109X(22)00271-6
- Authors: Vallely AJB, Saville M, Badman SG, et al.
- Findings: 4,285 women were recruited; 647 (15.1%) tested positive for one or more oncogenic HPV types.; Sensitivity for high-grade squamous intraepithelial lesion or worse was 85.4% (95% CI 81.0 to 89.6), specificity 89.6%, positive predictive value 35.2% and negative predictive value 98.9%.; 602 of the HPV-positive women (93.0%) received same-day thermal ablation; 42 were referred for gynaecology review and 37 of them attended.; Of 329 women seen at 3 months, 51 (15.5%) reported mild symptoms that had resolved; there were no serious adverse events.
- What it means: A woman in Papua New Guinea can take her own sample, get the result and, if needed, be treated in a single visit.
- Caveats: Two clinics with an on-site consultant gynaecologist, chosen with health authorities; results at less well staffed sites may differ.; Single-arm design, without a comparison group in the same trial.

## Sources

- DOI: https://doi.org/10.1016/S2214-109X(22)00271-6
- PubMed: https://pubmed.ncbi.nlm.nih.gov/35878625/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [HPV DNA testing and self-sampling](https://onco.cc/technologies/hpv-testing/), [Thermal ablation and cryotherapy for cervical precancer](https://onco.cc/technologies/precancer-ablation/)
- institutions: [National Department of Health, Papua New Guinea](https://onco.cc/institutions/png-national-department-of-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-vallely-hpv-stat-png-lancetgh-2022.json